Christian Marques Couto, Cecilia Vidal Watkins, Ricardo Silva Carvalho, Eduardo Boiteux Uchoa Cavalcanti, Alessandra De La Roque Ferreira, Waneska Souza Lima, Osvaldo José Moreira Nascimento
{"title":"Primary lateral sclerosis in Brazil: phenotypic heterogeneity, non-motor features, and prognostic markers in a 17-year multicentre cohort.","authors":"Christian Marques Couto, Cecilia Vidal Watkins, Ricardo Silva Carvalho, Eduardo Boiteux Uchoa Cavalcanti, Alessandra De La Roque Ferreira, Waneska Souza Lima, Osvaldo José Moreira Nascimento","doi":"10.1080/21678421.2026.2652325","DOIUrl":null,"url":null,"abstract":"<p><p><i>Objective:</i> Primary lateral sclerosis (PLS) is a rare upper motor neuron disorder within the motor neuron disease spectrum. Data from Latin America remains limited. We aimed to characterize clinical phenotypes, non-motor features, and prognostic markers in a systematically adjudicated Brazilian PLS cohort. <i>Methods:</i> In this retrospective multicenter study, we analyzed the data of 81 patients meeting the Turner 2020 criteria for probable/definite PLS at SARAH Network Hospitals (2007-2023). Clinical phenotyping, neurophysiology, <i>C9orf72</i> testing, and survival analyses were conducted. <i>Results:</i> The participants' median age at onset was 54 years (interquartile range 46-62); 53% of them were men. The onset distribution was as follows: lower limb 65%, bulbar 22%, and upper limb 11%. Extrapyramidal signs (7%) identified high-risk patients with fourfold increased mortality (relative risk [RR] 4.2, <i>p</i> = 0.013) and sixfold increased cognitive impairment (RR 6.3, <i>p</i> = 0.007). Eight patients (9.9%) exhibited hemiparetic presentations, with two meeting the definite Mills syndrome criteria; seven patients progressed to generalized PLS. Non-motor features were common: pseudobulbar affect (51%), urinary urgency (57%), and cognitive impairment (11%). Family history was observed in 10% and <i>C9orf72</i> expansion in 3%, with intrafamilial phenotypic variability. Five-year survival was excellent (98%) without onset-site effect (hazard ratio 0.80, <i>p</i> = 0.697). Two patients maintained isolated corticobulbar syndrome for 50-71 months. <i>Conclusions:</i> This first Latin American PLS cohort demonstrates clinical characteristics comparable to those reported in international studies. Extrapyramidal signs emerged as a high-risk marker. Hemiparetic presentations appear transitional, and non-motor manifestations support PLS as a multisystem disorder.</p>","PeriodicalId":72184,"journal":{"name":"Amyotrophic lateral sclerosis & frontotemporal degeneration","volume":" ","pages":"767-776"},"PeriodicalIF":2.8000,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Amyotrophic lateral sclerosis & frontotemporal degeneration","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/21678421.2026.2652325","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/13 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Primary lateral sclerosis (PLS) is a rare upper motor neuron disorder within the motor neuron disease spectrum. Data from Latin America remains limited. We aimed to characterize clinical phenotypes, non-motor features, and prognostic markers in a systematically adjudicated Brazilian PLS cohort. Methods: In this retrospective multicenter study, we analyzed the data of 81 patients meeting the Turner 2020 criteria for probable/definite PLS at SARAH Network Hospitals (2007-2023). Clinical phenotyping, neurophysiology, C9orf72 testing, and survival analyses were conducted. Results: The participants' median age at onset was 54 years (interquartile range 46-62); 53% of them were men. The onset distribution was as follows: lower limb 65%, bulbar 22%, and upper limb 11%. Extrapyramidal signs (7%) identified high-risk patients with fourfold increased mortality (relative risk [RR] 4.2, p = 0.013) and sixfold increased cognitive impairment (RR 6.3, p = 0.007). Eight patients (9.9%) exhibited hemiparetic presentations, with two meeting the definite Mills syndrome criteria; seven patients progressed to generalized PLS. Non-motor features were common: pseudobulbar affect (51%), urinary urgency (57%), and cognitive impairment (11%). Family history was observed in 10% and C9orf72 expansion in 3%, with intrafamilial phenotypic variability. Five-year survival was excellent (98%) without onset-site effect (hazard ratio 0.80, p = 0.697). Two patients maintained isolated corticobulbar syndrome for 50-71 months. Conclusions: This first Latin American PLS cohort demonstrates clinical characteristics comparable to those reported in international studies. Extrapyramidal signs emerged as a high-risk marker. Hemiparetic presentations appear transitional, and non-motor manifestations support PLS as a multisystem disorder.